Eco Animal Health Group PLC Notice of AGM (8409I)

TIDMEAH

RNS Number : 8409I

Eco Animal Health Group PLC

10 August 2023

10 August 2023

ECO Animal Health Group plc ("the Company")

(AIM: EAH)

Annual General Meeting

ECO Animal Health Group plc , a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, i s pleased to announce that the Company is today posting to shareholders notice of the Company's Annual General Meeting ("AGM") to be held at The Grange, 100 High Street, London, N14 6BN on Thursday 7 September 2023 at 2:30pm and Form of Proxy.

A copy of the notice of AGM and Form of Proxy will be available from the Company's website

www.ecoanimalhealthgroupplc.com/investor-relations.aspx

Contacts

 
 
   ECO Animal Health Group plc 
   David Hallas (Chief Executive Officer) 
   Christopher Wilks (Chief Financial Officer)     020 8447 8899 
 IFC Advisory 
  Graham Herring 
  Zach Cohen                                      020 3934 6630 
 Singer Capital Markets (Nominated Adviser 
  & Joint Broker) 
  Philip Davies 
  George Tzimas 
  Sam Butcher                                       020 7496 3000 
 Investec (Joint Broker) 
  Gary Clarence 
  Carlo Spingardi 
  Lydia Zychowska                                   020 7597 5970 
 
 
 Equity Development 
  Hannah Crowe 
  Matt Evans           020 7065 2692 
 

About ECO Animal Health

ECO Animal Health Group plc ("ECO" or "the "GROUP") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOASSDFLUEDSEFA

(END) Dow Jones Newswires

August 10, 2023 02:00 ET (06:00 GMT)